Kubota Y, London S J, Cushman M, Chamberlain A M, Rosamond W D, Heckbert S R, Zakai N, Folsom A R
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
J Thromb Haemost. 2016 Dec;14(12):2394-2401. doi: 10.1111/jth.13525. Epub 2016 Nov 8.
Essentials The association of lung function with venous thromboembolism (VTE) is unclear. Chronic obstructive pulmonary disease (COPD) patterns were associated with a higher risk of VTE. Symptoms were also associated with a higher risk of VTE, but a restrictive pattern was not. COPD may increase the risk of VTE and respiratory symptoms may be a novel risk marker for VTE.
Background The evidence for the association between chronic obstructive pulmonary disease (COPD) and venous thromboembolism (VTE) is limited. There is no study investigating the association between restrictive lung disease (RLD) and respiratory symptoms with VTE. Objectives To investigate prospectively the association of lung function and respiratory symptoms with VTE. Patients/Methods In 1987-1989, we assessed lung function by using spirometry, and obtained information on respiratory symptoms (cough, phlegm, and dyspnea) in 14 654 participants aged 45-64 years, without a history of VTE or anticoagulant use, and followed them through 2011. Participants were classified into four mutually exclusive groups: 'COPD' (forced expiratory volume in 1 s [FEV ]/forced vital capacity [FVC] below the lower limit of normal [LLN]), 'RLD' (FEV /FVC ≥ LLN and FVC < LLN), 'respiratory symptoms with normal spirometic results' (without RLD or COPD), and 'normal' (without respiratory symptoms, RLD, or COPD). Results We documented 639 VTEs (238 unprovoked and 401 provoked VTEs). After adjustment for VTE risk factors, VTE risk was increased for individuals with either respiratory symptoms with normal spirometric results (hazard ratio [HR] 1.40, 95% confidence interval [CI] 1.12-1.73) or COPD (HR 1.33, 95% CI 1.07-1.67) but not for those with RLD (HR 1.15, 95% CI 0.82-1.60). These elevated risks of VTE were derived from both unprovoked and provoked VTE. Moreover, FEV and FEV /FVC showed dose-response relationships with VTE. COPD was more strongly associated with pulmonary embolism than with deep vein thrombosis. Conclusions Obstructive spirometric patterns were associated with an increased risk of VTE, suggesting that COPD may increase the risk of VTE. Respiratory symptoms may represent a novel risk marker for VTE.
要点 肺功能与静脉血栓栓塞(VTE)之间的关联尚不清楚。慢性阻塞性肺疾病(COPD)模式与VTE风险较高相关。症状也与VTE风险较高相关,但限制性模式并非如此。COPD可能会增加VTE风险,而呼吸道症状可能是VTE的一个新的风险标志物。
背景 慢性阻塞性肺疾病(COPD)与静脉血栓栓塞(VTE)之间关联的证据有限。尚无研究调查限制性肺病(RLD)及呼吸道症状与VTE之间的关联。目的 前瞻性调查肺功能及呼吸道症状与VTE之间的关联。患者/方法 在1987 - 1989年,我们通过肺活量测定法评估了14654名年龄在45 - 64岁、无VTE病史或未使用抗凝剂的参与者的肺功能,并获取了有关呼吸道症状(咳嗽、咳痰和呼吸困难)的信息,随访至2011年。参与者被分为四个相互排斥的组:“COPD”(1秒用力呼气容积[FEV₁]/用力肺活量[FVC]低于正常下限[LLN])、“RLD”(FEV₁/FVC≥LLN且FVC<LLN)、“肺活量测定结果正常但有呼吸道症状”(无RLD或COPD)和“正常”(无呼吸道症状、RLD或COPD)。结果 我们记录了639例VTE(238例不明原因和401例诱因明确的VTE)。在对VTE危险因素进行调整后,肺活量测定结果正常但有呼吸道症状的个体(风险比[HR]1.40,95%置信区间[CI]1.12 - 1.73)或COPD个体(HR 1.33,95%CI 1.07 - 1.67)的VTE风险增加,但RLD个体(HR 1.15,95%CI 0.82 - 1.60)并非如此。这些VTE风险升高源自不明原因和诱因明确的VTE。此外,FEV₁和FEV₁/FVC与VTE呈剂量反应关系。COPD与肺栓塞的关联比与深静脉血栓形成的关联更强。结论 阻塞性肺活量测定模式与VTE风险增加相关,提示COPD可能会增加VTE风险。呼吸道症状可能是VTE的一个新的风险标志物。